Maternal obesity, metabolic health, and prenatal programming of offspring obesity

Open Obesity Journal

Volumn 3, Issue , 2011, Pages 42-50

  Chandler Laney, Paula C ^a   Bush, Nikki C ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Adiposity; BMI; Dyslipidemia; Family history; Gestational diabetes; Hypertension; Inflammation; Metabolic health; Recent weight gain; Waist circumference

Indexed keywords

C REACTIVE PROTEIN; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; TRIACYLGLYCEROL;

BIRTH WEIGHT; BODY MASS; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; DYSLIPIDEMIA; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN RESISTANCE; LARGE FOR GESTATIONAL AGE; LIPID BLOOD LEVEL; MATERNAL DIABETES MELLITUS; MATERNAL DISEASE; MATERNAL HYPERTENSION; MATERNAL WELFARE; METABOLIC SYNDROME X; METABOLISM; OBESITY; PREECLAMPSIA; PREGNANCY; PRENATAL CARE; PRIORITY JOURNAL; PROGENY; REVIEW; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WEIGHT GAIN;

EID: 79955066686     PISSN: None     EISSN: 18768237     Source Type: Journal    
DOI: 10.2174/1876823701103010042     Document Type: Review

References (104)

1. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295(13): 1549-55.
2. Chu SY, Callaghan WM, Kim SY, et al. Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care 2007; 30(8): 2070-6.
3. Butte NF, Ellis KJ, Wong WW, Hopkinson JM, Smith EO. Composition of gestational weight gain impacts maternal fat retention and infant birth weight. Am J Obstet Gynecol 2003; 189(5): 1423-32.
4. Hammami M, Walters JC, Hockman EM, Koo WW. Disproportionate alterations in body composition of large for gestational age neonates. J Pediatr 2001; 138(6): 817-21.
5. Sun M, Schutz Y, Grezzani A, Clementi M, Gaudino R, Maffeis C. Body size and early growth in appropriate- and large-forgestational- age infants. Acta Paediatr 2003; 92(10): 1127-32.
6. [Whitaker RC. Predicting preschooler obesity at birth: the role of maternal obesity in early pregnancy. Pediatrics 2004; 114(1): e29-36.
7. Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005; 115(3): e290-6.
8. Harvey NC, Poole JR, Javaid MK, et al. Parental determinants of neonatal body composition. J Clin Endocrinol Metab 2007; 92(2): 523-6.
9. Sewell MF, Huston-Presley L, Super DM, Catalano P. Increased neonatal fat mass, not lean body mass, is associated with maternal obesity. Am J Obstet Gynecol 2006; 195(4): 1100-3.
10. [Hull HR, Dinger MK, Knehans AW, Thompson DM, Fields DA. Impact of maternal body mass index on neonate birthweight and body composition. Am J Obstet Gynecol 2008; 198(4): 416.e1-6.
11. Burdette HL, Whitaker RC, Hall WC, Daniels SR. Maternal infantfeeding style and children's adiposity at 5 years of age. Arch Pediatr Adolesc Med 2006; 160(5): 513-20.
12. Gale CR, Javaid MK, Robinson SM, Law CM, Godfrey KM, Cooper C. Maternal size in pregnancy and body composition in children. J Clin Endocrinol Metab 2007; 92: 3904-11.
13. Catalano PM, Farrell K, Thomas A, et al. Perinatal risk factors for childhood obesity and metabolic dysregulation. Am J Clin Nutr 2009; 90(5): 1303-13.
14. Mingrone G, Manco M, Mora ME, et al. Influence of maternal obesity on insulin sensitivity and secretion in offspring. Diabetes Care 2008; 31(9): 1872-6.
15. [Getahun D, Ananth CV, Peltier MR, Salihu HM, Scorza WE. Changes in prepregnancy body mass index between the first and second pregnancies and risk of large-for-gestational-age birth. Am J Obstet Gynecol 2007; 196(6): 530.e1-8.
16. [Kral JG, Biron S, Simard S, et al. Large maternal weight loss from obesity surgery prevents transmission of obesity to children who were followed for 2 to 18 years. Pediatrics 2006; 118(6): e1644-9.
17. Dabelea D, Hanson RL, Lindsay RS, et al. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes 2000; 49(11): 2208-11.
18. Levin BE, Govek E. Gestational obesity accentuates obesity in obesity-prone progeny. Am J Physiol 1998; 275(4 Pt 2): R1374-9.
19. Shankar K, Harrell A, Liu X, Gilchrist JM, Ronis MJ, Badger TM. Maternal obesity at conception programs obesity in the offspring. Am J Physiol Regul Integr Comp Physiol 2008; 294(2): R528-38.
20. White CL, Purpera MN, Morrison CD. Maternal obesity is necessary for programming effect of high-fat diet on offspring. Am J Physiol Regul Integr Comp Physiol 2009; 296(5): R1464-72.
21. Barker DJP. Mothers, babies, and disease in later life. 2nd ed. New York: Churchill Livingstone 1998.
22. Pedersen J. The pregnant diabetic and her newborn: problems and management. Baltimore, MD: Williams & Wilkens 1967.
23. Whitaker RC, Dietz WH. Role of the prenatal environment in the development of obesity. J Pediatr 1998; 132: 768-76.
24. Catalano PM, Ehrenberg HM. The short- and long-term implications of maternal obesity on the mother and her offspring. BJOG 2006; 113(10): 1126-33.
25. Ramsay JE, Ferrell WR, Crawford L, Wallace AM, Greer IA, Sattar N. Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. J Clin Endocrinol Metab 2002; 87(9): 4231-7.
26. Yogev Y, Visser GH. Obesity, gestational diabetes and pregnancy outcome. Semin Fetal Neonatal Med 2009; 14(2): 77-84.
27. [Damm P. Future risk of diabetes in mother and child after gestational diabetes mellitus. Int J Gynaecol Obstet 2009; 104 Suppl 1: S25-6.
28. [Smith GN, Walker MC, Liu A, et al. A history of preeclampsia identifies women who have underlying cardiovascular risk factors. Am J Obstet Gynecol 2009; 200(1): 58.e1-8.
29. Di Cianni G, Lencioni C, Volpe L, et al. C-reactive protein and metabolic syndrome in women with previous gestational diabetes. Diabetes Metab Res Rev 2007; 23(2): 135-40.
30. Torloni MR, Betrán AP, Horta BL, et al. Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obes Rev 2009; 10(2): 194-203.
31. Silverman BL, Rizzo T, Green OC, et al. Long-term prospective evaluation of offspring of diabetic mothers. Diabetes 1991; 40 Suppl 2: 121-5.
32. Gillman MW, Rifas-Shiman S, Berkey CS, Field AE, Colditz GA. Maternal gestational diabetes, birth weight, and adolescent obesity. Pediatrics 2003; 111(3): e221-6.
33. Catalano PM, Thomas A, Huston-Presley L, Amini SB. Increased fetal adiposity: a very sensitive marker of abnormal in utero development. Am J Obstet Gynecol 2003;189(6):1698-704.
34. Yogev Y, Langer O, Xenakis EM, Rosenn B. The association between glucose challenge test, obesity and pregnancy outcome in 6390 non-diabetic women. J Matern Fetal Neonatal Med 2005; 17(1): 29-34.
35. Jensen DM, Korsholm L, Ovesen P, Beck-Nielsen H, Mølsted- Pedersen L, Damm P. Adverse pregnancy outcome in women with mild glucose intolerance: is there a clinically meaningful threshold value for glucose? Acta Obstet Gynecol Scand 2008; 87(1): 59-62.
36. The HAPO Study cooperative research group. Hyperglycemia and adverse pregnancy outcome (HAPO) study. Diabetes 2009; 58: 453-9.
37. Vohr BR, McGarvey ST. Growth patterns of large-for-gestationalage and appropriate-for-gestational-age infants of gestational diabetic mothers and control mothers at age 1 year. Diabetes Care 1997; 20(7): 1066-72.
38. Vohr BR, Boney CM. Gestational diabetes: the forerunner for the development of maternal and childhood obesity and metabolic syndrome? J Matern Fetal Neonatal Med 2008; 21(3): 149-57.
39. Metzger BE. Long-term outcomes in mothers diagnosed with gestational diabetes mellitus and their offspring. Clin Obstet Gynecol 2007; 50(4): 972-9.
40. Wright CS, Rifas-Shiman SL, Rich-Edwards JW, Taveras EM, Gillman MW, Oken E. Intrauterine exposure to gestational diabetes, child adiposity, and blood pressure. Am J Hypertens 2009; 22(2): 215-20.
41. Group HSCR. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991-2002.
42. D'Anna R, Baviera G, Cannata ML, De Vivo A, Di Benedetto A, Corrado F. Midtrimester amniotic fluid leptin and insulin levels and subsequent gestational diabetes. Gynecol Obstet Invest 2007; 64(2): 65-8.
43. Silverman BL, Rizzo TA, Cho NH, Metzger BE. Long-term effects of the intrauterine environment. The Northwestern University Diabetes in Pregnancy Center. Diabetes Care 1998; 21 Suppl 2: B142-9.
44. Bouret SG. Early life origins of obesity: Role of hypothalamic programming. J Pediatr Gastroenterol Nutr 2009; 48 Suppl 1: S31-8.
45. Plagemann A. A matter of insulin: Developmental programming of body weight regulation. J Matern Fetal Neonatal Med 2008; 21(3): 143-8.
46. Crowther CA, Hiller JE, Moss JR, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005; 352(24): 2477-86.
47. Uvena-Celebrezze J, Fung C, Thomas AJ, et al. Relationship of neonatal body composition to maternal glucose control in women with gestational diabetes mellitus. J Matern Fetal Neonatal Med 2002; 12(6): 396-401.
48. Hillier TA, Pedula KL, Schmidt MM, Mullen JA, Charles MA, Pettitt DJ. Childhood obesity and metabolic imprinting: the ongoing effects of maternal hyperglycemia. Diabetes Care 2007; 30(9): 2287-92.
49. Bevier WC, Fischer R, Jovanovic L. Treatment of women with an abnormal glucose challenge test (but a normal oral glucose tolerance test) decreases the prevalence of macrosomia. Am J Perinatol 1999; 16(6): 269-75.
50. Sacks DA, Liu AI, Wolde-Tsadik G, Amini SB, Huston-Presley L, Catalano PM. What proportion of birth weight is attributable to maternal glucose among infants of diabetic women? Am J Obstet Gynecol 2006; 194(2): 501-7.
51. Ricart W, López J, Mozas J, et al. Body mass index has a greater impact on pregnancy outcomes than gestational hyperglycaemia. Diabetologia 2005; 48(9): 1736-42.
52. Bo S, Menato G, Signorile A, Bardelli C, et al. Obesity or diabetes: what is worse for the mother and for the baby? Diabetes Metab 2003; 29(2 Pt 1): 175-8.
53. Miller RS, Thompson ML, Williams MA. Trimester-specific blood pressure levels in relation to maternal pre-pregnancy body mass index. Paediatr Perinat Epidemiol 2007; 21(6): 487-94.
54. Bodnar LM, Ness RB, Markovic N, Roberts JM. The risk of preeclampsia rises with increasing prepregnancy body mass index. Ann Epidemiol 2005; 15(7): 475-82.
55. Thadhani R, Stampfer MJ, Hunter DJ, Manson JE, Solomon GC, Curhan GC. High body mass index and hypercholesterolemia: Risk of hypertensive disorders of pregnancy. Obstet Gynecol 1999; 94: 543-50.
56. Sibai BM, Ewell M, Levine RJ, et al. Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol 1997; 177(5): 1003-10.
57. Xiong X, Demianczuk NN, Buekens P, Saunders LD. Association of preeclampsia with high birth weight for age. Am J Obstet Gynecol 2000; 183(1): 148-55.
58. Stella CL, O'Brien JM, Forrester KJ, et al. The coexistence of gestational hypertension and diabetes: influence on pregnancy outcome. Am J Perinatol 2008; 25(6): 325-9.
59. Herrera E, Amusquivar E, López-Soldado I, Ortega H. Maternal lipid metabolism and placental lipid transfer. Horm Res 2006; 65 (Suppl 3): 59-64.
60. Wiznitzer A, Mayer A, Novack V, et al. Association of lipid levels during gestation with preeclampsia and gestational diabetes mellitus: a population-based study. Am J Obstet Gynecol 2009; 201(5): 482.el-8.
61. Di Cianni G, Miccoli R, Volpe L, et al. Maternal triglyceride levels and newborn weight in pregnant women with normal glucose tolerance. Diabet Med 2005; 22(1): 21-5.
62. Knopp RH, Magee MS, Walden CE, Bonet B, Benedetti TJ. Prediction of infant birth weight by GDM screening tests. Importance of plasma triglyceride. Diabetes Care 1992; 15(11): 1605-13.
63. Nolan CJ, Riley SF, Sheedy MT, Walstab JE, Beischer NA. Maternal serum triglyceride, glucose tolerance, and neonatal birth weight ratio in pregnancy. Diabetes Care 1995; 18(12): 1550-6.
64. Kitajima M, Oka S, Yasuhi I, Fukuda M, Rii Y, Ishimaru T. Maternal serum triglyceride at 24--32 weeks' gestation and newborn weight in nondiabetic women with positive diabetic screens. Obstet Gynecol 2001; 97(5 Pt 1): 776-80.
65. Schaefer-Graf UM, Graf K, Kulbacka I, et al. Maternal lipids as strong determinants of fetal environment and growth in pregnancies with gestational diabetes mellitus. Diabetes Care 2008; 31(9): 1858-63.
66. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Low-grade systemic inflammation in overweight children. Pediatrics 2001; 107(1): E13.
67. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999; 282(22): 2131-5.
68. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342(12): 836-43.
69. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. Creactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286(3): 327-34.
70. Retnakaran R, Hanley AJ, Raif N, Connelly PW, Sermer M, Zinman B. C-reactive protein and gestational diabetes: the central role of maternal obesity. J Clin Endocrinol Metab 2003; 88(8): 3507-12.
71. Wolf M, Sandler L, Hsu K, Vossen-Smirnakis K, Ecker JL, Thadhani R. First-trimester C-reactive protein and subsequent gestational diabetes. Diabetes Care 2003; 26(3): 819-24.
72. Tjoa ML, van Vugt JM, Go AT, Blankenstein MA, Oudejans CB, van Wijk IJ. Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction. J Reprod Immunol 2003; 59(1): 29-37.
73. Qiu C, Sorensen TK, Luthy DA, Williams MA. A prospective study of maternal serum C-reactive protein (CRP) concentrations and risk of gestational diabetes mellitus. Paediatr Perinat Epidemiol 2004; 18(5): 377-84.
74. Dahlgren J, Nilsson C, Jennische E, et al. Prenatal cytokine exposure results in obesity and gender-specific programming. Am J Physiol Endocrinol Metab 2001; 281(2): E326-34.
75. Radaelli T, Uvena-Celebrezze J, Minium J, Huston-Presley L, Catalano P, Hauguel-de Mouzon S. Maternal interleukin-6: marker of fetal growth and adiposity. J Soc Gynecol Investig 2006; 13(1): 53-7.
76. Aaltonen R, Heikkinen T, Hakala K, Laine K, Alanen A. Transfer of proinflammatory cytokines across term placenta. Obstet Gynecol 2005; 106(4): 802-7.
77. Zaretsky MV, Alexander JM, Byrd W, Bawdon RE. Transfer of inflammatory cytokines across the placenta. Obstet Gynecol 2004; 103(3): 546-50.
78. Catalano PM, Presley L, Minium J, Hauguel-de Mouzon S. Fetuses of obese mothers develop insulin resistance in utero. Diabetes Care 2009; 32(6): 1076-80.
79. Nelson SM, Sattar N, Freeman DJ, Walker JD, Lindsay RS. Inflammation and endothelial activation is evident at birth in offspring of mothers with type 1 diabetes. Diabetes 2007; 56(11): 2697-704.
80. Yogev Y, Langer O, Brustman L, Rosenn B. Pre-eclampsia and gestational diabetes mellitus: does a correlation exist early in pregnancy? J Matern Fetal Neonatal Med 2004; 15(1): 39-43.
81. Lykke JA, Langhoff-Roos J, Sibai BM, Funai EF, Triche EW, Paidas MJ. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension 2009; 53(6): 944-51.
82. Colatrella A, Braucci S, Festa C, et al. Hypertensive Disorders in Normal/Over-weight and Obese Type 2 Diabetic Pregnant Women. Exp Clin Endocrinol Diabetes 2009; 117(8): 373-7.
83. Joffe GM, Esterlitz JR, Levine RJ, et al. The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women. Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol 1998; 179(4): 1032-7.
84. Fasting MH, Oken E, Mantzoros CS, et al. Maternal levels of corticotropin-releasing hormone during pregnancy in relation to adiponectin and leptin in early childhood. J Clin Endocrinol Metab 2009; 94(4): 1409-15.
85. Andres R. The effect of obesity on total mortality. Int J Obes (Lond) 1980; 4: 381-6.
86. Ruderman LB, Berchtold P, Schneider S. Obesity-associated disorders in normal-weight individuals: Some speculations. Int J Obes (Lond) 1982; 6 Suppl 1: 151-7.
87. Sims EAH. Characterization of the syndromes of obesity. In: Brodoff BN, Bleicher SJ, eds. Diabetes Mellitus and Obesity. Baltimore: Williams & Wilkins 1982: 219-26.
88. Conus F, Rabasa-Lhoret R, Péronnet F. Characteristics of metabolically obese normal-weight (MONW) subjects. Appl Physiol Nutr Metab 2007; 32(1): 4-12.
89. Karelis AD, Brochu M, Rabasa-Lhoret R. Can we identify metabolically healthy but obese individuals (MHO)? Diabetes Metab 2004; 30(6): 569-72.
90. Sims EAH. Are there persons who are obese, but metabolically healthy? Metabolism 2001; 50(12): 1499-504.
91. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S. The metabolically obese, normal-weight individual revisited. Diabetes 1998; 47: 699-713.
92. Bonora E, Kiechl J, Willeit J, et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 1998; 47(10): 1643-9.
93. Muscelli E, Camastra S, Gastaldelli A, et al. Influence of duration of obesity on the insulin resistance of obese non-diabetic patients. Int J Obes Relat Metab Disord 1998; 22(3): 262-7.
94. Brochu M, Tchernof A, Dionne IJ, et al. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab 2001; 86(3): 1020-5.
95. Pouliot MC, Després JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994; 73(7): 460-8.
96. Sattar N, Clark P, Holmes A, Lean ME, Walker I, Greer IA. Antenatal waist circumference and hypertension risk. Obstet Gynecol 2001; 97(2): 268-71.
97. Branchtein L, Schmidt MI, Mengue SS, Reichelt AJ, Matos MC, Duncan BB. Waist circumference and waist-to-hip ratio are related to gestational glucose tolerance. Diabetes Care 1997; 20(4): 509-11.
98. Bitó T, Földesi I, Nyári T, Pál A. Prediction of gestational diabetes mellitus in a high-risk group by insulin measurement in early pregnancy. Diabet Med 2005; 22(10): 1434-9.
99. Poon LC, Kametas NA, Chelemen T, Leal A, Nicolaides KH. Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach. J Hum Hypertens 2010; 24(2): 104-10.
100. Kim C, Liu T, Valdez R, Beckles GL. Does frank diabetes in firstdegree relatives of a pregnant woman affect the likelihood of her developing gestational diabetes mellitus or nongestational diabetes? Am J Obstet Gynecol 2009; 201(6): 576.e1-6.
101. Tabák AG, Tamás G, Péterfalvi A, et al. The effect of paternal and maternal history of diabetes mellitus on the development of gestational diabetes mellitus. J Matern Fetal Neonatal Med 2009; 32(7): 606-10.
102. Lu GC, Luchesse A, Chapman V, Cliver S, Rouse DJ. Screening for gestational diabetes mellitus in the subsequent pregnancy: is it worthwhile? Am J Obstet Gynecol 2002; 187(4): 918-21.
103. Villamor E, Cnattingius S. Interpregnancy weight change and risk of adverse pregnancy outcomes: a population-based study. Lancet 2006; 368(9542): 1164-70.
104. Levy A, Wiznitzer A, Holcberg G, Mazor M, Sheiner E. Family history of diabetes mellitus as an independent risk factor for macrosomia and cesarean delivery. J Matern Fetal Neonatal Med 2010; 32(2): 148-52.